SCHEMBL3960401

SCHEMBL3960401

CCOCCN1C(=O)NC2(C(=O)Nc3ccc(Cl)cc32)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 4/20 0.41
IDO1 P14902 2/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40
HTR7 P34969 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
MAPK1 P28482 1/20 0.37
GAA P10253 2/20 0.37
CBX7 O95931 1/20 0.37
CDYL2 Q8N8U2 1/20 0.37
CDYL Q9Y232 1/20 0.37
CDY1; CDY1B Q9Y6F8 1/20 0.37
HPGD P15428 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
CYP2C9 P11712 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
AKR1A1 P14550 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4167818 0.81 AKR1B1 (0.46) AKR1B1CBX7CDYLAKR1A1
SCHEMBL2483991 0.76 CNR1 (0.51) ALDH1A1KMT2A
SCHEMBL3960398 0.75 IDO1 (0.42) AKR1B1IDO1HTR7CBX7CDYL2
SCHEMBL2486352 0.74 PTGDR2 (0.62) AKR1B1IDO1CYP2C9
SCHEMBL4160906 0.73 AKR1B1 (0.37) AKR1B1ALDH1A1HTTAKR1A1
SCHEMBL2484248 0.72 PTGDR2 (0.64) ALDH1A1HTR7GAALMNAMEN1
SCHEMBL3954635 0.71 PTGDR2 (0.39) AKR1B1IDO1CBX7CDYL2CDYL
SCHEMBL4543280 0.71 NPC1 (0.43) AKR1B1ALDH1A1GAAHPGDLMNA
SCHEMBL4979426 0.71 CNR1 (0.51) AKR1B1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL13589453 0.69 POLB (0.40) AKR1B1IDO1CBX7CDYL2CDYL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013216-A2 NOVEL SPIRO [IMIDAZOLIDINE-4, 3' -INDOLE] 2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 AstraZeneca AB (SE) 2009-01-14 EP disclosed
WO-2007091948-A2 NOVEL SPIRO [IMIDAZOLIDINE-4, 3´-INDOLE] 2, 2´,5´(1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 ASTRAZENECA AB (SE) 2007-08-16 WO disclosed